Published in Biochemistry on October 18, 1988
Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists. Biochemistry (2005) 1.09
1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activity. J Med Chem (2014) 0.82
Beta-turn secondary structure and melanocortin ligands. Bioorg Med Chem (2008) 0.76
"Click"-cyclized (68)Ga-labeled peptides for molecular imaging and therapy: synthesis and preliminary in vitro and in vivo evaluation in a melanoma model system. Recent Results Cancer Res (2013) 0.75
Fluorescence study of conformational properties of melanotropins labeled with aminobenzoic acid. Biophys J (2001) 0.75
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A (1983) 3.17
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A (1980) 2.80
Activation of two signal-transduction systems in hepatocytes by glucagon. Nature (1986) 2.21
Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA (1991) 1.93
alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. J Med Chem (1987) 1.75
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem (1989) 1.54
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther (1984) 1.45
Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides (1991) 1.37
Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes. Biochem J (1990) 1.37
Sensitivity- and gradient-enhanced hetero (omega1) half-filtered TOCSY experiment for measuring long-range heteronuclear coupling constants. J Magn Reson (1998) 1.34
Molecular biology and pharmacology of cloned opioid receptors. FASEB J (1995) 1.34
Alpha-melanotropin: the minimal active sequence in the lizard skin bioassay. Gen Comp Endocrinol (1989) 1.34
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci U S A (1994) 1.32
Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci (1982) 1.32
Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J (2000) 1.32
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol (2010) 1.30
Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity. J Pept Res (2004) 1.25
D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem (2000) 1.25
Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J Med Chem (1986) 1.24
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol (1998) 1.23
Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. Proc Natl Acad Sci U S A (1996) 1.23
Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science (1986) 1.22
Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci (1996) 1.22
Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science (1982) 1.18
The dermal chromatophore unit. J Cell Biol (1968) 1.17
Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci (1992) 1.16
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin. Life Sci (1992) 1.15
Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. J Med Chem (1997) 1.14
[half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity. Proc Natl Acad Sci U S A (1982) 1.14
NMR studies on the conformation of derivatives of the side chain of oxytocin: examples of cis-trans isomerism. Proc Natl Acad Sci U S A (1971) 1.14
Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J Pharmacol Exp Ther (1989) 1.13
[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain. J Pharmacol Exp Ther (1989) 1.13
In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. J Pharmacol Exp Ther (1993) 1.12
Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin. Science (1981) 1.10
Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration. J Pharmacol Exp Ther (1991) 1.07
Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin. J Org Chem (2001) 1.07
Multivalent melanotropic peptide and fluorescent macromolecular conjugates: new reagents for characterization of melanotropin receptors. Bioconjug Chem (1995) 1.06
Topographical requirements for delta-selective opioid peptides. Biopolymers (1991) 1.06
Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin. Bioorg Med Chem Lett (1999) 1.05
Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15). Proc Natl Acad Sci U S A (1985) 1.05
Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain (1995) 1.05
Preparation of 'side-chain-to-side-chain' cyclic peptides by Allyl and Alloc strategy: potential for library synthesis. J Pept Res (2001) 1.05
Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology. Biopolymers (1996) 1.04
The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism. Biochem J (1987) 1.04
Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo. J Pharmacol Exp Ther (1996) 1.04
Role of central melanocortins in endotoxin-induced anorexia. Am J Physiol (1999) 1.04
Spontaneous electrical potentials and pituitary hormone (MSH) secretion. Nature (1976) 1.04
Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am J Physiol Regul Integr Comp Physiol (2000) 1.04
Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity. Life Sci (1983) 1.02
Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. J Pharmacol Exp Ther (1997) 1.02
Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives. J Pharmacol Exp Ther (1996) 1.01
Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins. J Med Chem (1984) 1.01
Pigment cell signalling for physiological color change. Comp Biochem Physiol A Physiol (1997) 1.01
Improved bioavailability to the brain of glycosylated Met-enkephalin analogs. Brain Res (2000) 1.00
[D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity. Biochem Biophys Res Commun (1982) 1.00
Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides (1996) 1.00
Physiological color changes in reptiles. Am Zool (1969) 1.00
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J Med Chem (2000) 1.00
Fast, efficient and selective deprotection of the tert-butoxycarbonyl (Boc) group using HCl/dioxane (4 m). J Pept Res (2001) 1.00
Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther (1995) 1.00
Exploring Ramachandran and chi space: conformationally constrained amino acids and peptides in the design of bioactive polypeptide ligands. Curr Med Chem (2004) 1.00
The effect of halogenation on blood-brain barrier permeability of a novel peptide drug. Peptides (1999) 0.99
Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology (2000) 0.99
Peptide opioid antagonist separates peripheral and central opioid antitransit effects. J Pharmacol Exp Ther (1987) 0.98
Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sci (1986) 0.98
Effect of peptide conformation on membrane permeability. J Pept Res (2003) 0.97
Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. J Pharmacol Exp Ther (1984) 0.96
Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence. J Med Chem (1985) 0.96
Multiple release of equimolar amounts of peptides from a polymeric carrier using orthogonal linkage-cleavage chemistry. Int J Pept Protein Res (1993) 0.95
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des Discov (1996) 0.95
Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J Pharmacol Exp Ther (1993) 0.95
Chromatophores and color change in the lizard, Anolis carolinensis. Z Zellforsch Mikrosk Anat (1970) 0.95
Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. J Neurochem (1996) 0.95
Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. J Med Chem (1997) 0.95
Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Proc Natl Acad Sci U S A (1977) 0.95
Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides (1997) 0.95